Recent News
On December 3, 2025 the board declared a one-time cash dividend of $2.00 per share, payable January 21, 2026 to shareholders of record January 6, 2026.
On January 28, 2026 the company confirmed fourth-quarter results and reported quarterly revenue of $1,174 million and basic and diluted EPS of $0.70 for the 2025 fourth quarter.
Technical Analysis
Trend Strength (ADX): ADX at 27.56 signals a strong market trend; coupling that strength with declining DI+ and a DI- dip-and-reversal signals the current strength favors sellers rather than buyers, which pressures near-term price bias.
Directional Indicators (DI+/DI-): DI+ at 24.92 has decreased, a bearish development, while DI- at 16.23 shows a dip-and-reversal that also registers as bearish; together they indicate directional pressure toward lower short-term prices unless buyers regain DI+ momentum.
MACD: MACD sits at 2.92 below its signal line at 3.70, with a peak-and-reversal pattern that signals waning bullish momentum and aligns with a short-term bearish momentum profile.
MRO (Momentum/Regression Oscillator): MRO at -0.37 places price marginally below the model target, indicating modest upside potential to close that gap, but the magnitude remains small and does not offset the broader loss of momentum signaled elsewhere.
RSI: RSI at 59.75 with a peak-and-reversal indicates momentum has pulled back from recent highs without reaching overbought levels, leaving room for mean reversion but showing waning upside impetus.
Price vs Averages and Bands: Last close $150.00 sits below the 20-day average $154.06 and the 12-day EMA $152.66 (the 12-day EMA shows a peak-and-reversal), while remaining above the 200-day average $134.09; short-term bias therefore shows weakness within a longer-term uptrend. Bollinger band edges near $151.59–$156.54 imply current price trades near the lower-to-middle band range, supporting the view of contained short-term downside potential.
Volume & Volatility: Today’s volume 800,756 exceeds the 10-day average 520,236 and 200-day average 418,549, suggesting elevated trading interest during the momentum shift; 42- and 52-week volatility at 2% indicate relatively low realized volatility for the stock.
Fundamental Analysis
Earnings and Estimates: Reported EPS $0.75 missed the estimate $1.09 by -$0.34, an EPS surprise of -31.19%, reflecting a material shortfall versus consensus expectations for the quarter.
Earnings Growth: Quarter-over-quarter earnings declined by -24.11%, while year-over-year earnings increased by 4.43%, showing recent quarterly softness against modest annual improvement.
Revenue and Cash Cycle: Reported revenue growth registers at 0.0% with both QoQ and YoY entries at -1.0 (reported values); the cash conversion cycle stands at 0 days with a QoQ change of -1 day, indicating tight working-capital handling.
Capital Structure & Cost: Cost of debt 0.646% shows a low after-tax borrowing cost; invested capital appears as -$309,295,000 in the reported line item and should be reviewed in company filings for context.
Valuation Multiples: Trailing PE sits at 189.68, above the industry peer mean of 165.17 and well above the industry peer median of 34.44; forward PE equals 81.15, above the industry peer mean of 46.40 but below the industry peer high of 101.61. Forward EPS equals $1.677. The company’s PEG ratio stands negative at -4.92 while forward PEG sits at -2.11, reflecting earnings and growth dynamics embedded in current multiples.
Profitability & Returns: Reported earnings growth metric shows an overall negative reading of -38.53% in the provided summary line while the explicit QoQ and YoY percentages above capture recent quarter and annual movement; reconcile these figures with filings for detailed segment breakdowns.
Valuation Assessment: The current valuation as determined by WMDST places the stock as over-valued, a conclusion driven by elevated trailing and forward multiples relative to peer averages combined with the recent earnings miss and mixed growth signals.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-01-28 |
| NEXT REPORT DATE: | 2026-04-29 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 1.09 | |
| EPS Actual | $ 0.75 | |
| EPS Difference | $ -0.34 | |
| EPS Surprise | -31.193 % | |
| Forward EPS | $ 1.68 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 189.675 | |
| Price To Earnings QoQ | 78.14 % | |
| Price To Earnings YoY | 40.825 % | |
| Price To Earnings IPRWA | high: 260.531 LSTR: 189.675 mean: 165.172 median: 34.44 low: -9.844 |
|
| PE/G Ratio | -4.923 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 81.146 | |
| Forward PE/G | -2.106 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 0.0 | |
| Cash Conversion Cycle Days QoQ | -100.0 % | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -309.30 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.646 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | — | |
| Earnings Growth | -38.525 % | |
| Earnings Growth QoQ | -2411.038 % | |
| Earnings Growth YoY | 443.218 % | |
| Earnings Growth IPRWA | high: 66.667 % mean: 25.849 % low: -12.143 % median: -12.143 % LSTR: -38.525 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | — | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |